Purple Biotech Ltd.
Purple Biotech Ltd. (PPBT) Revenue
Annual & quarterly revenue history · segment & region breakdown
PPBT · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsPurple Biotech Ltd. trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from $0.00B in FY2025.
Revenue trend
2025 – 2013 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $0.00B | +$0.00B | — |
| 2024-12-31 | $0.00B | -$0.00B | -100.00% |
| 2023-12-31 | $0.00B | +$0.00B | — |
| 2022-12-31 | $0.00B | +$0.00B | — |
| 2021-12-31 | $0.00B | -$0.00B | -100.00% |
| 2020-12-31 | $0.00B | +$0.00B | +0.00% |
| 2019-12-31 | $0.00B | +$0.00B | +0.00% |
| 2018-12-31 | $0.00B | +$0.00B | +900.00% |
| 2017-12-31 | $0.00B | +$0.00B | — |
| 2016-12-31 | $0.00B | +$0.00B | — |
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Purple Biotech Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Purple Biotech Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Purple Biotech Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
PPBT revenue · 4 questionsPPBT's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from $0.00B in FY2025.
▸ Source: FMP · Purple Biotech Ltd. SEC filings · GAAP · Purple Biotech Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026